An observational study in Lung Cancer, sponsored by University College London Hospitals. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-12.
Sponsored by University College London Hospitals · Observational
The goal of this observational study is to improve the early detection of lung cancer in adults who have smoked less than 100 tobacco cigarettes ("never-smokers") in the United Kingdom. The main questions it aims to answer are:
Participants will currently have no change to their usual care.
5,422 studies on the registry are indexed under Lung Neoplasms; 1,346 are open to participants now.
This study's planned enrollment of 225 is above the median of 200 across 1,434 observational studies indexed under Lung Neoplasms.
Browse Lung Neoplasms studies →University College London Hospitals is the lead sponsor of 62 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
This study will aim to recruit participants who have been diagnosed or treated with primary lung cancer at any participating study site.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants who have ever smoked cigarettes or tobacco will be excluded; this is defined as:
Demographics, comorbidities and environmental exposures of participants
From review of electronic health records
Time frame: Comorbidities and environmental exposures at diagnosis (approximately up to 156 weeks prior to diagnosis)
Participant pathways including presentation mode and symptoms
From review of electronic health records
Time frame: Presentation mode and symptoms at time of diagnosis (approximately up to 52 weeks prior to diagnosis)
Participant outcomes such as cancer stage, treatment, mortality
From review of electronic health records
Time frame: Cancer stage at time of diagnosis, treatment and mortality through study completion (likely 5 years)
Measurement of modifiable and non-modifiable factors associated with LCINS
To be determined
Time frame: Through study completion (likely 5 years)
Plan to share: No — No individual participant data will be made available to non-study researchers (as per current ethics approval).
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University College London Hospitals